Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/18/2026 | CALL | $26.50 | 8,500 | +8,500 | |
| 06/18/2026 | PUT | $26.50 | 8,500 | +8,500 | |
| 05/15/2026 | CALL | $27.00 | 53,808 | +2,168 | +4.20% |
| 06/18/2026 | CALL | $27.00 | 39,836 | +1,886 | +4.97% |
| 05/22/2026 | CALL | $29.00 | 5,007 | +1,450 | +40.76% |
| 09/18/2026 | CALL | $30.00 | 28,664 | +1,368 | +5.01% |
| 05/15/2026 | CALL | $26.00 | 2,930 | -414 | -12.38% |
| 05/08/2026 | CALL | $27.50 | 13,715 | -615 | -4.29% |
| 05/01/2026 | CALL | $28.00 | 21,416 | -919 | -4.11% |
| 05/01/2026 | PUT | $27.50 | 554 | -4,164 | -88.26% |
| 05/01/2026 | CALL | $26.50 | 1,230 | -8,500 | -87.36% |
| 05/01/2026 | PUT | $26.50 | 1,230 | -8,500 | -87.36% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
05/01 12:43 pm
GlobeNewswire Inc.
Read moreModerna's Legal Hit Steals Spotlight From Strong Sales
05/01 10:44 am
Benzinga
Read moreShould You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
04/30 03:10 am
The Motley Fool
Read morePfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
04/29 02:41 pm
Benzinga
Read moreRetatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
04/29 11:00 am
GlobeNewswire Inc.
Read moreDietary Supplements Market Driven by Health and Nutrition Demand
04/29 03:31 am
GlobeNewswire Inc.
Read moreAntibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence
04/28 03:52 am
GlobeNewswire Inc.
Read moreAI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation
04/27 01:36 pm
GlobeNewswire Inc.
Read morePeripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
04/27 01:00 pm
GlobeNewswire Inc.
Read moreRelay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
04/27 06:00 am
GlobeNewswire Inc.
Read moreIs This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?
04/25 01:05 pm
The Motley Fool
Read moreTACO Trade Joke No More? Trump's Art Of The Deal' Powers S&P 500's Steepest Highs And Lows
04/24 07:31 am
Benzinga
Read moreOmics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
04/24 04:59 am
GlobeNewswire Inc.
Read moreMental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
04/24 04:57 am
GlobeNewswire Inc.
Read moreLevicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
04/24 04:00 am
GlobeNewswire Inc.
Read moreChronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight
04/23 01:00 pm
GlobeNewswire Inc.
Read moreLarge Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
04/22 02:20 pm
Benzinga
Read moreNurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
04/22 07:00 am
GlobeNewswire Inc.
Read moreA Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
04/21 07:30 am
The Motley Fool
Read moreBispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook
04/21 04:34 am
GlobeNewswire Inc.
Read moreThis Drug Stock Has Crushed the S&P 500 Over the Last Decade
04/18 05:15 pm
The Motley Fool
Read moreNon-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight
04/16 01:00 pm
GlobeNewswire Inc.
Read moreInvesting $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
04/14 09:30 am
The Motley Fool
Read more$5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036
04/13 04:44 am
GlobeNewswire Inc.
Read moreAtopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline
04/10 04:52 am
GlobeNewswire Inc.
Read moreAtopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033
04/10 04:46 am
GlobeNewswire Inc.
Read moreCrohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032
04/10 04:43 am
GlobeNewswire Inc.
Read moreSerina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
04/07 06:00 am
GlobeNewswire Inc.
Read moreTrump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime
04/06 01:20 pm
Investing.com
Read moreDéclaration d'actions et de droits de vote de la société Valneva SE - Mars 2026
04/03 02:30 am
GlobeNewswire Inc.
Read more3 Monster Dividend Stocks to Hold for the Next 10 Years
04/02 05:15 am
The Motley Fool
Read moreTrump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report
04/02 04:44 am
Benzinga
Read moreEsophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate
03/30 05:00 am
GlobeNewswire Inc.
Read morePrediction: Buying Pfizer Stock Today Could Set You Up for Life
03/29 08:15 pm
The Motley Fool
Read more1 Reason This Biotech Stock Could Triple Before Year-End
03/29 12:30 am
The Motley Fool
Read moreCould Buying Eli Lilly Today Set You Up for Life?
03/26 03:15 pm
The Motley Fool
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
03/24 05:49 pm
GlobeNewswire Inc.
Read moreSerina Therapeutics to Present at the 38th Annual Roth Conference
03/24 06:00 am
GlobeNewswire Inc.
Read moreValneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
03/23 10:35 am
Benzinga
Read moreHave $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now
03/23 05:15 am
The Motley Fool
Read moreMy Top 3 Drug Stocks for March 2026
03/20 06:30 am
The Motley Fool
Read more5 ‘Healthy’ Dividends Paying Up to 14.1%
03/20 05:16 am
Investing.com
Read morePfizer vs Moderna: Which Pharma Stock Has More Upside?
03/19 03:30 pm
The Motley Fool
Read morePfizer Combo Therapy Scores Major Win In Prostate Cancer Trial
03/19 11:19 am
Benzinga
Read moreIs It Too Late to Buy Eli Lilly?
03/19 11:15 am
The Motley Fool
Read moreThe Best Healthcare Stocks to Buy With $50 Right Now
03/18 08:30 am
The Motley Fool
Read morePfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients
03/17 10:39 am
Benzinga
Read more